Matinas BioPharma (MTNB) Announces Issuance of US Patent for Prescription-Only Next Generation Omega-3 MAT9001

  1. Matinas BioPharma (MTNB) Announces Issuance of US Patent for Prescription-Only Next Generation Omega-3 MAT9001  StreetInsider.com

  2. Matinas BioPharma Announces Issuance of Key US Patent for Prescription-Only Next Generation Omega-3 MAT9001 …  GlobeNewswire (press release)
  3. Matinas BioPharma shares pop on patent approval for MAT9001  Proactive Investors USA & Canada

    4. Full coverage